Join us for the 3^rd annual Bringing Chemistry to Medicine symposium, a virtual event featuring talks by leading experts from around the globe working at the interface of chemical and biomedical sciences. Speakers represent expertise across a spectrum of research areas, including therapeutic regulation of transcription and chromatin, computational biology, and chemical biology. The event will span two days with focused themes: Transcription Therapy on Thursday, July 21, 2022, and Frontiers in Chemical Biology, on Friday, July 22, 2022

This symposium, hosted by the St. Jude Department of Chemical Biology and Therapeutics and the St. Jude Comprehensive Cancer Center, is a component of the institution’s strategic objective to establish a global hub focused on the emerging field of transcription-targeted therapeutics.

To enable broad participation and interaction among trainees and scientists around the world, registration is free.

Speakers

July 21, 2022
Scott Armstrong, MD, PhD
Dana-Farber Cancer Institute

Bradley Bernstein, MD, PhD
Dana Farber Cancer Institute

Clifford Brangwynne, PhD
Princeton University

Jolanta Grembecka, PhD
University of Michigan

Tanja Mittag, PhD
St. Jude Children’s Research Hospital

Geeta Narlikar, PhD
University of California, San Francisco

Fraydoon Rastinejad, PhD
University of Oxford

Ken Zaret, PhD
University of Pennsylvania

July 22, 2022
Ray Deshaies, PhD
Amgen, Inc.

Matt Disney, PhD
Scripps Research Institute (Florida)

Ron Dror, PhD
Stanford University

Dorothee Kern, PhD
Brandeis University

Judith Klinman, PhD
University of California, Berkeley

David Moore, PhD
University of California, Berkeley

Peter Schultz, PhD
Scripps Research Institute (La Jolla)

Derek Tan, PhD
Memorial Sloan Kettering Cancer Center